FH-Risk 2.0: Updating Breast Cancer Risk Estimates
Study Details
Study Description
Brief Summary
In the UK women with a strong family history of breast cancer are eligible for breast cancer risk estimation via Family History Risk and Prevention Clinics (FHRPCs). Here breast cancer risk is calculated using popular risk prediction models like the Tyrer-Cuzick, CanRisk or Gail models. These models combine breast cancer risk factors to calculate a risk estimate for women. Risk factors include, family history, hormonal and reproductive factors, and risk factors related to health behaviours, for example, smoking, exercise and alcohol intake.
Recently, risk estimation for breast cancer has become more accurate with the inclusion of mammographic density and Single Nucleotide Polymorphisms (SNPs) into popular risk prediction models. The addition of these new risk factors could alter the risk estimates that women in FHRPCs have been provided. How much these new risk factors alter a previously given risk estimate is unknown. It is also unknown how women will react to a revised risk estimate, especially if it changes their previous estimate and their access to preventive management options.
This research aims to explore this gap in the literature.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Estimation of breast cancer risk is important since it enables selection of a high and moderate risk population who benefit from more frequent breast screening and the introduction of targeted measures to reduce risk such as lifestyle change, chemoprevention and risk reducing surgery. Traditionally, risk is estimated by combining information concerning family history and non-familial factors, such as age of menarche and first pregnancy. Subsequent management is related to the degree of risk (high, moderate or average) according to NICE guidelines. Members of the research team and others have added mammographic density (MD) and breast cancer risk associated single nucleotide polymorphisms (SNPs) to risk models which improves the accuracy of risk estimation but which may change the original given risk and risk management given before the updated models became available.
The objective of this body of work is to quantify change in risk and risk management when MD and SNPs are incorporated into two standard models (Tyrer-Cuzick v8 & BOADACEA V). A second objective of the study is to determine the psychological effects of change of risk and management.
This work will use participant data from the Family History Risk (FH-Risk) study to recalculate risk. The FH-Risk study population consists of 954 women referred to the Family History Risk and Prevention Clinic (FHRPC) between 2000 and 2012 who gave informed consent for DNA testing and estimation of MD as part of the FH-Risk study which recruited between 2010 and 2012. Change in risk and management will be calculated by comparing given risk at the time of clinic entry compared with re-estimated risk when MD and SNPs are added to the risk models according to NICE guidelines. Risk will be estimated retrospectively at the time of entry to the clinic and the time of latest follow up.
A sample of those who took part in the FH-Risk study who are still in the FHRPC for follow-up (approx.271) will be the first set of women to be given the opportunity to discuss their updated risk. The research team appreciate that women who were part of the FH-Risk study who have been discharged should also be given the opportunity to learn of a potential change in their breast cancer risk. The team do have plans to provide risk feedback to these women in a follow-up study to the present one described here.
The work presented here will enable us to determine the optimal way to provide this feedback by beginning with women whose immediate care could be changed as a result of their updated breast cancer risk estimate. It is therefore logical to start with women who are still in follow-up at the clinic.
Following the risk update consultation a sample of women will be asked whether they would like to take part in an interview to assess the psychological effects of the change, as well as their views and perceptions of the change. These interviews will inform the development of information materials for communicating recalculated risk. These materials will be appraised via 'think aloud' interviews with women from the FH-Risk study who have received their recalculated risk.
The results of this work are likely to inform the next iteration of NICE management guidelines for Family History Clinics, as well as inform the creation of patient facing information materials to aid patient - healthcare professional communication. The findings will also be used to develop a questionnaire to be given to women who previously took part in the FH-Risk study (and who have been discharged from the clinic) to assess the psychological impact of changed risk in a definitive study.
This body of work is split into 3 studies:
Study 1 - risk recalculation
Risk recalculation will be performed for all women who took part in the original FH-Risk study, with women still under follow up at the FHRPC given the opportunity to attend a consultation to discuss their revised breast cancer risk estimate.
Study 2 - women's experiences of receiving a revised breast cancer risk estimate.
One to one semi-structured interviews will be conducting with women from study 1 to explore their experiences of receiving a revised breast cancer risk estimate. Breast cancer risk appraisals, the trustworthiness of the estimate, women's emotional responses will all be considered in these interviews. Information and communication needs will also be explored.
Study 3 - women's appraisals of information materials for women who have received a revised breast cancer risk estimate
Women in this study will read a suite of information materials which have been designed to explain why they have received a revised breast cancer risk estimate. Information materials will be designed for women who have had change to their risk, be that an increase or decrease and for women where their risk estimate has remained the same.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Women with a family history of breast cancer This women are register to the Family History Risk and Prevention clinic and have taken part in the original FH-Risk study. These women will be given the opportunity to learn of their revised breast cancer risk estimate. |
Other: Notification of a revised breast cancer risk estimate
These women will be given the opportunity to learn of their revised breast cancer risk estimate which has been re-calculated with the inclusion of new strong independent risk factors. These women will be offered a clinical consultation to discuss their risk and will a subset will be asked to take part in a qualitative interview about their experiences.
|
Outcome Measures
Primary Outcome Measures
- To explore how much new risk models change breast cancer risk estimates [1 - 2 years]
How do new risk models which include mammographic density, SNPs and mutation testing change breast cancer risk estimates in women who are still registered at the family history clinic. Scatterplots and correlation coefficients will be used to examine the relationships between models and Bland-Altman plots used to show the agreement between the models.
- To compare breast cancer risk models [1 - 2 years]
Comparing the risk estimations given by the Tyrer-Cuzick and CanRisk models. Scatterplots and correlation coefficients will be used to examine the relationships between models and Bland-Altman plots used to show the agreement between the models.
- To explore women's risk appraises and experiences of receiving a revised breast cancer risk estimate [Through to study completion, 2.5 years]
How do women react to receiving a revised breast cancer risk estimate, especially if their risk has changed. What are their risk perceptions following a revised estimate. This will assessed through qualitative interviews.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
previously given informed consent to participate in the original FH-Risk study,
-
have an up to date clear mammogram,
-
still in follow up at the family history clinic,
-
aged between 25 and 60,
-
have not developed breast cancer and,
-
have the capacity to consent.
Exclusion Criteria:
-
women who have received a diagnosis of breast cancer,
-
women who have not had a clear mammogram,
-
women who have been discharged from the family history clinic,
-
women who took part in the original FH-Risk study but did not consent for their data to be used in future research and,
-
women who lack the capacity to consent.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Manchester University NHS Foundation Trust | Manchester | Greater Manchester | United Kingdom | M23 9QZ |
Sponsors and Collaborators
- University of Manchester
- Manchester University NHS Foundation Trust
Investigators
- Principal Investigator: Gareth Evans, Manchester University NHS Foundation Trust
- Principal Investigator: Anthony Howell, Manchester University NHS Foundation Trust
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- FH-Risk 2.0 Research Protocol